DR. MANISH KUMAR AGHI, MD PHD
Medical Practice at Parnassus Ave, San Francisco, CA

License number
California A101651
Category
Medical Practice
Type
Neurological Surgery
Address
Address
400 Parnassus Ave ROOM A808, San Francisco, CA 94143
Phone
(415) 353-2948
(415) 353-2889 (Fax)

Personal information

See more information about MANISH KUMAR AGHI at radaris.com
Name
Address
Phone
Manish Aghi, age 51
2122 14Th Ave, San Francisco, CA 94116
(415) 682-4500
Manish Aghi
5448 Golubin Cmn, Fremont, CA 94555
Manish K Aghi, age 51
2122 14Th St, San Francisco, CA 94116
(415) 682-4500
Manish K Aghi
2122 14Th Ave, San Francisco, CA 94116

Professional information

Manish Kumar Aghi Photo 1

Manish Kumar Aghi, San Francisco CA

Specialties:
Neurological Surgery, Surgery
Work:
UCSF Medical Center / Moffitt-Long Hospitals
400 Parnassus Ave, San Francisco, CA 94143 San Francisco Va Medical Center
4150 Clement St, San Francisco, CA 94121 University of California at San Francisco
521 Parnassus Ave, San Francisco, CA 94143
Education:
Harvard University(2000)


Manish K Aghi Photo 2

Dr. Manish K Aghi, San Francisco CA - MD (Doctor of Medicine)

Specialties:
Neurosurgery
Age:
50
Address:
UCSF Medical Center NSG/NEU ONC
400 Parnassus Ave SUITE A808, San Francisco 94143
(415) 353-7500 (Phone)
Certifications:
Neurosurgery, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UCSF Medical Center NSG/NEU ONC
400 Parnassus Ave SUITE A808, San Francisco 94143
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
Education:
Medical School
Harvard Medical School
Graduated: 2000


Manish Aghi Photo 3

Methods And Compositions For Improving Antiangiogenic Therapy With Anti-Integrins

US Patent:
2014007, Mar 20, 2014
Filed:
Mar 22, 2012
Appl. No.:
14/006669
Inventors:
Warren Shawn Carbonell - San Francisco CA, US
Manish Kumar Aghi - San Francisco CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 39/395, A61K 49/00
US Classification:
424 91, 4241741, 4241331, 4241351, 4241361, 435375
Abstract:
Described here are methods and compositions for treating tumors and metastases that improve anti-angiogenesis therapy. By inhibiting these mechanisms in a biological system with an anti-beta one integrin composition in combination with an anti-angiogenic composition, tumors and metastases may be deprived of an adequate blood supply, thereby resulting in tumor cell growth arrest and possibly regression, including tumor cell death. The present compositions comprise an anti-beta one integrin agent in combination with an anti-VEGF agent, in a pharmaceutical composition or compositions. Methods of treatment and of imaging are also described.